Cytarabine Dose for Acute Myeloid Leukemia REPLY

被引：0
|
作者：
Lowenberg, Bob [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 22期
关键词：
CHEMOTHERAPY; THERAPY; INDUCTION; ADULTS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2168 / 2169
页数：2
相关论文
共 50 条
  • [31] Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
    Walter, Roland B.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    LEUKEMIA, 2021, 35 (02) : 295 - 298
  • [32] Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review
    Arwanih, Elly Y.
    Louisa, Melva
    Rinaldi, Ikhwan
    Wanandi, Septelia I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [33] Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
    Rosenblat, Todd L.
    McDevitt, Michael R.
    Mulford, Deborah A.
    Pandit-Taskar, Neeta
    Divgi, Chaitanya R.
    Panageas, Katherine S.
    Heaney, Mark L.
    Chanel, Suzanne
    Morgenstern, Alfred
    Sgouros, George
    Larson, Steven M.
    Scheinberg, David A.
    Jurcic, Joseph G.
    CLINICAL CANCER RESEARCH, 2010, 16 (21) : 5303 - 5311
  • [34] A Randomized Phase 2 Study of Idarubicin and Cytarabine With Clofarabine or Fludarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia
    Jabbour, Elias
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Xiao, Lianchun
    Garcia-Manero, Guillermo
    Plunkett, William
    Gandhi, Varsha
    Sasaki, Koji
    Pemmaraju, Naveen
    Daver, Naval G.
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Kadia, Tapan M.
    Wierda, William G.
    DiNardo, Courtney D.
    Brandt, Mark
    O'Brien, Susan M.
    Cortes, Jorge E.
    Kantarjian, Hagop
    CANCER, 2017, 123 (22) : 4430 - 4439
  • [35] Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics
    Zhou, Ji-hao
    Lin, Hai-qing
    Shen, Qi
    Hu, Li-na
    Li, Guo-qiang
    Sun, Xiong-fei
    Zhang, Xin-you
    CURRENT MEDICAL SCIENCE, 2018, 38 (01) : 51 - 57
  • [36] MITOXANTRONE AND CYTARABINE VERSUS DAUNORUBICIN AND CYTARABINE IN PREVIOUSLY UNTREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    WAHLIN, A
    HORNSTEN, P
    HEDENUS, M
    MALM, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (06) : 480 - 483
  • [37] Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
    Jaramillo, S.
    Benner, A.
    Krauter, J.
    Martin, H.
    Kindler, T.
    Bentz, M.
    Salih, H. R.
    Held, G.
    Koehne, C-H
    Goetze, K.
    Luebbert, M.
    Kuendgen, A.
    Brossart, P.
    Wattad, M.
    Salwender, H.
    Hertenstein, B.
    Nachbaur, D.
    Wulf, G.
    Horst, H-A
    Kirchen, H.
    Fiedler, W.
    Raghavachar, A.
    Russ, G.
    Kremers, S.
    Koller, E.
    Runde, V.
    Heil, G.
    Weber, D.
    Goehring, G.
    Doehner, K.
    Ganser, A.
    Doehner, H.
    Schlenk, R. F.
    BLOOD CANCER JOURNAL, 2017, 7 : e564 - e564
  • [38] Prophylactic use of granulocyte colony-stimulating factor after consolidation therapy with high-dose cytarabine for acute myeloid leukemia
    Shadman, Mazyar
    Estey, Elihu H.
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (02) : 131 - 133
  • [39] Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia
    Liu, Jiazhuo
    Mi, Yingchang
    Fu, Mingwei
    Yu, Wenjuan
    Wang, Ying
    Lin, Dong
    Bian, Shougeng
    Wang, Jianxiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (07) : 422 - 427
  • [40] Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia
    Sekeres, Mikkael A.
    Lancet, Jeffrey E.
    Wood, Brent L.
    Grove, Laurie E.
    Sandalic, Larissa
    Sievers, Eric L.
    Jurcic, Joseph G.
    HAEMATOLOGICA, 2013, 98 (01) : 119 - 128
12345